Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 10Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Breast Neoplasms 580Neoplasms 487Prostatic Neoplasms 311Lung Neoplasms 238Colorectal Neoplasms 201Motor Activity 131Carcinoma, Non-Small-Cell Lung 117Uterine Cervical Neoplasms 112Brain Neoplasms 110Pancreatic Neoplasms 108Head and Neck Neoplasms 106Stomach Neoplasms 99Carcinoma, Hepatocellular 99Rectal Neoplasms 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 67Multiple Myeloma 65Esophageal Neoplasms 65Hematologic Neoplasms 61Urinary Bladder Neoplasms 60Glioblastoma 59Melanoma 58Sarcoma 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Endometrial Neoplasms 56Glioma 53Lymphoma 50Leukemia, Myeloid, Acute 48Gastrointestinal Neoplasms 48

Interventions

Sufentanil 1Electroacupuncture 1((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Postoperative Nausea and Vomiting × Clear all
NCT07479446 2026-05-22

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Xuanwu Hospital, Beijing

Phase NA Recruiting
174 enrolled
CNS

Neuroma, Acoustic, Postoperative Nausea and Vomiting

NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Shanghai Chest Hospital

Phase NA Recruiting
204 enrolled

Postoperative Nausea and Vomiting

NCT07480785 2026-03-18

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Zhejiang University

Phase NA Recruiting
780 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Postoperative Nausea and Vomiting, Gallstones

Data powered by HemOnc (CC BY 4.0) Colophon âš¡